Catalyst Wire Dossier Catalyst Wire Dossier

BI 1467335

BI 1467335 · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for BI 1467335, covering 2020-06-11 to 2021-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects [Phase 1]

See pricing